Abstract:We found that maximum positive surgical margin (PSM) length > 5.0 mm and the International Society of Urological Pathology grade group at the PSM ≥3 were particularly strong predictive factors for biochemical recurrence (BCR) after robot‐assisted radical prostatectomy (RARP). We could stratify patients according to the detailed PSM status. This risk classification might be useful to predict early BCR and help guide urologists in decision‐making in relation to additional treatment after RARP . Aim This study aimed to evaluate the risk classification system using the detailed positive surgical margin (PSM) status to predict biochemical recurrence (BCR) after robot‐assisted radical prostatectomy (RARP). Methods We retrospectively analyzed 427 patients who underwent RARP between January 2016 and March 2020. We investigated risk factors for BCR using univariate and multivariate Cox proportional hazard regression models. The biochemical recurrence‐free survival (BRFS) rate was assessed using the Kaplan‐Meier method. Results The median follow‐up period was 43.4 months and 99 patients developed BCR. In the multivariate analysis, maximum PSM length > 5.0 mm and the International Society of Urological Pathology grade group (ISUP GG) at the PSM ≥3 were predictive factors for BCR in patients with a PSM. In the multivariate analysis, these factors were also independent predictive factors in the overall study population, including patients without a PSM. We classified the patients into four groups using these factors and found that the 1‐year BRFS rates in the negative surgical margin (NSM) group, low‐risk group (PSM and neither factor), intermediate‐risk group (either factor), and high‐risk group (both factors) were 94.9%, 94.5%, 83.1%, and 52.9%, respectively. The low‐risk group showed similar BRFS to the NSM group (p = 0.985), while the high‐risk group had significantly worse BRFS than the other groups (p 5.0 mm and ISUP GG at the PSM ≥3 were independent predictive factors for BCR after RARP. Risk classification for BCR using these factors is considered to be useful and might help urologists decide on additional treatment after RARP.

Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94)

Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group)

Development of risk-score model in patients with negative surgical margin after robot-assisted radical prostatectomy

Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral Center

Risk classification system using the detailed positive surgical margin status for predicting biochemical recurrence after robot‐assisted radical prostatectomy

Predictors of Progression to Castration-resistant Prostate Cancer After Radical Prostatectomy in High-risk Prostate Cancer Patients

Implications of unconventional histological subtypes on magnetic resonance imaging and oncological outcomes in patients who have undergone radical prostatectomy

Effects of aging on complications following robot-assisted radical prostatectomy

Biparametric Prostate Imaging Reporting and Data System version2 and International Society of Urological Pathology Grade Predict Biochemical Recurrence after Radical Prostatectomy

Can Pelvic Lymph Node Dissection in Prostate Cancer Patients with a 5% Briganti Nomogram Cut-off Value Provide an Oncological Benefit? A Large Multi-Institutional Cohort Study in Japan

Tertiary Gleason Pattern 5 is An Independent Risk Factor for Prostate Cancer with GS 7: A Retrospective Study from China.

Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer

The impact of prognostic group classification on prostate cancer progression in intermediate-risk patients according to the European Association of Urology system: results in 479 patients treated with robot-assisted radical prostatectomy at a single tertiary referral center

Predictors of surgical difficulty according to surgical proficiency in robot-assisted radical prostatectomy

Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy

Real-world data on the comprehensive genetic profiling test for Japanese patients with metastatic castration-resistant prostate cancer

Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer

Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort

Six-year outcomes of robot-assisted radical prostatectomy versus volumetric modulated arc therapy for localized prostate cancer: A propensity score-matched analysis

Predictive factors of actual 5‐y recurrence‐free survival after upfront surgery for resectable pancreatic cancer

Predictors of biochemical recurrence after robot-assisted radical prostatectomy: single-centre analysis